share_log

BRIEF-Macrogenics Announces Achievement Of $10 Mln Milestone Related To Retifanlimab Collaboration With Incyte

BRIEF-Macrogenics Announces Achievement Of $10 Mln Milestone Related To Retifanlimab Collaboration With Incyte

Brief-MacroGenics宣佈實現與Retifan limab與Incell合作的1000萬美元里程碑
路透社 ·  2021/02/11 22:11

Feb 11 (Reuters) - MacroGenics Inc :
   * MACROGENICS ANNOUNCES ACHIEVEMENT OF $10 MILLION MILESTONE RELATED TO RETIFANLIMAB COLLABORATION WITH INCYTE

Source text for Eikon:  Further company coverage:

((Reuters.Briefs@thomsonreuters.com;)

路透2月11日電-MacroGenics Inc：*MacroGenics宣佈與ReTIFANLIMAB與Incell合作相關的1000萬美元里程碑Eikon的源文本：進一步的公司報道：(Reurs.Briefs@thomsonreurs.com；)

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論